NHS ADHD Services, Private Treatment & Shared Care Support
A comprehensive guide to understanding NHS ADHD services, private ADHD treatment pathways, waiting times, shared care arrangements, and how to access ADHD medication across different care routes in the UK.
Understanding NHS ADHD Services
NHS ADHD services provide assessment, diagnosis, and treatment through publicly funded healthcare pathways at no direct cost to the patient. They are commissioned by Integrated Care Boards (ICBs) and delivered through NHS mental health trusts, CAMHS services, and increasingly approved independent providers under Right to Choose arrangements.
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition affecting an estimated 2.5% of adults and 5% of children in the UK. NHS ADHD services are the primary route through which most patients access formal assessment, diagnosis, and treatment, providing a structured pathway from GP referral through to ongoing medication management and specialist review.
NHS ADHD services typically cover:
- Structured ADHD assessments conducted by qualified specialists
- Formal ADHD diagnosis where criteria are met
- Prescribing of licensed ADHD medications including stimulants and non-stimulants
- Ongoing monitoring and medication review appointments
- Access to psychological interventions and support services where available
- Shared Care Agreement facilitation for ongoing GP prescribing
The NHS ADHD assessment pathway typically begins with a GP referral to a local specialist ADHD service or, under the NHS Right to Choose framework in England, a patient-initiated referral to an approved independent ADHD assessment provider. Right to Choose pathways have been used by many patients to access faster assessments while remaining within NHS funding.
NHS ADHD Waiting Times
NHS ADHD waiting times vary significantly depending on location, service demand, and local NHS resources. Waiting periods differ between regions, providers, and patient age groups. Some patients have accessed faster pathways through the NHS Right to Choose framework in England, which allows self-referral to approved independent ADHD assessment providers within NHS funding.
NHS ADHD waiting times are among the most frequently discussed aspects of ADHD care in the UK. Demand for ADHD assessments has increased substantially in recent years, driven by greater public awareness, improved understanding of how ADHD presents across different populations, and an increase in adults seeking assessment for conditions that were not identified in childhood.
Several factors contribute to the variation in waiting times across different areas:
- Local NHS commissioning priorities and funding allocation
- Availability of trained ADHD specialists within each Integrated Care Board area
- Population size and demand relative to service capacity
- Whether Right to Choose pathways have been implemented locally
- Different referral thresholds and criteria between services
- Separate pathways for children, young people, and adults
Important: Waiting times change frequently and vary by location. Patients and clinicians should check current waiting times directly with local NHS services or the relevant Integrated Care Board. The information on this page is for general guidance only and does not reflect real-time waiting period data.
For patients unable to access NHS ADHD assessment within a timeframe that meets their clinical needs, private ADHD assessment is an option that can offer faster access to specialist evaluation. Where a patient is assessed and diagnosed privately and then wishes to access NHS support for ongoing management, Shared Care arrangements may be available subject to local policies and GP agreement.
Private ADHD Treatment Pathways
Private ADHD services allow patients to access ADHD assessment, diagnosis, and treatment through self-funded or health-insured routes. Private pathways typically offer faster appointment availability, access to specialist clinicians, and greater flexibility in service delivery but carry costs for each stage of the assessment and treatment process.
Private ADHD treatment in the UK follows a similar clinical pathway to NHS provision in terms of the diagnostic standards applied, but operates outside NHS commissioning. Private ADHD assessments are conducted by consultant psychiatrists, specialist ADHD clinicians, or accredited assessment services, and must adhere to NICE guidelines for ADHD diagnosis and treatment.
The Private ADHD Pathway
Self-referral or GP referral
Patients can self-refer to private ADHD assessment services or be referred by their GP. Private clinics typically do not require a GP referral, though it is advisable to inform your GP of any private assessment undertaken.
Private ADHD assessment
A comprehensive assessment is conducted by a qualified specialist, using standardised assessment tools and clinical interview. Assessments are typically completed in one or two appointments, significantly faster than many NHS pathways.
Diagnosis and treatment planning
Where ADHD criteria are met, a formal diagnosis is made and a treatment plan developed. For adults, this commonly involves medication alongside psychoeducation and, where appropriate, psychological support.
Medication initiation
The prescribing specialist initiates ADHD medication, typically starting at a low dose and titrating to an effective level. Private prescriptions are issued and can be dispensed at a specialist pharmacy such as Pharmazon HomeCare.
Ongoing monitoring and review
Regular review appointments monitor treatment response, side effects, and medication adjustments. Patients can continue privately or explore transition to NHS Shared Care for ongoing prescribing.
Cost considerations: Private ADHD treatment involves fees at each stage assessment, follow-up appointments, and private prescription costs. Patients should request a full fee breakdown from their chosen provider before proceeding. Some private health insurance policies cover ADHD assessment and treatment; check your policy for specific terms.
NHS vs Private ADHD Services: Key Differences
NHS ADHD services provide assessment, diagnosis, and treatment through publicly funded healthcare pathways at no direct cost to the patient, while private ADHD services offer access through self-funded or insured routes. The main differences typically relate to waiting times, appointment availability, treatment access speed, and costs associated with each stage of care.
| Factor | NHS ADHD Services | Private ADHD Services |
|---|---|---|
| Assessment availability | Variable — can involve significant waiting periods depending on location and provider | Typically faster; appointments often available within weeks |
| Cost to patient | No direct cost — funded by NHS | Fees apply for assessments, appointments, and prescriptions |
| Prescription costs | Standard NHS prescription charge (free for eligible patients) | Full medication cost plus dispensing fee on private prescription |
| Clinical standards | NICE guidelines required | NICE guidelines required same standards apply |
| Ongoing prescribing | Via NHS specialist or GP under Shared Care Agreement | Via private prescriber or transition to NHS Shared Care |
| Service flexibility | Follows NHS referral and appointment protocols | Greater scheduling flexibility; often more accessible appointment times |
| Specialist access | Allocated to local NHS service or Right to Choose provider | Patient choice of specialist or clinic |
| Medication delivery | Via NHS-contracted community pharmacy | Via specialist pharmacy with home delivery options |
Hybrid pathways: Some patients use private assessment and diagnosis to access faster confirmation of ADHD, then work with their GP to establish an NHS Shared Care arrangement for ongoing prescribing, combining faster initial access with reduced long-term prescription costs.
Exploring ADHD medication support for your clinic or patients?
Pharmazon HomeCare supports NHS and private ADHD patients with specialist prescription fulfilment, repeat prescribing management, and home delivery.
ADHD Medication Access: NHS and Private Pathways
ADHD medication access differs between NHS and private pathways primarily in terms of speed, prescription costs, and dispensing route. NHS prescriptions are issued by NHS-commissioned prescribers and dispensed at NHS prescription charges. Private prescriptions carry the full medication cost and are issued by private prescribers they can be dispensed at specialist pharmacy providers who support private ADHD patients.
ADHD medications in the UK are predominantly Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001. This designation applies to methylphenidate preparations (including Concerta XL, Ritalin, Medikinet, and Equasym XL), lisdexamfetamine (Elvanse), and dexamfetamine (Amfexa). Non-stimulant alternatives such as atomoxetine (Strattera) and guanfacine (Intuniv) are not controlled drugs but are similarly regulated as prescription-only medicines.
Because most ADHD medications are controlled drugs, their prescribing, dispensing, and supply are subject to specific regulatory requirements regardless of whether the prescription is NHS or private. Both prescription types require a suitably qualified, registered prescriber and a pharmacy with the appropriate controlled drug dispensing authority.
NHS Medication Access
- Prescribed by NHS specialist or GP under Shared Care Agreement
- Standard NHS prescription charge applies (or free for eligible patients)
- Dispensed at NHS-contracted community pharmacy
- Subject to local formulary restrictions in some areas
- Requires ongoing review appointments for continued prescribing
- Electronic Prescription Service (EPS) available for some medications
Private Medication Access
- Prescribed by authorised private prescriber or consultant psychiatrist
- Full medication cost plus dispensing fee applies
- Can be dispensed at specialist pharmacy with home delivery
- No local formulary restrictions, full range of licensed medications
- Same controlled drug regulatory requirements apply
- Pharmacy homecare providers can manage repeat prescribing cycles
Transitioning from Private ADHD Care to NHS Shared Care
In many cases, patients who receive their ADHD diagnosis and initial treatment privately may transition to NHS Shared Care arrangements for ongoing prescribing, subject to local NHS policies, clinical requirements, and GP agreement. This pathway can allow patients to benefit from faster private assessment while reducing the long-term cost burden of private prescriptions.
The transition from private ADHD care to NHS Shared Care is increasingly common, as more patients access private assessment to reduce waiting times before seeking to formalise NHS support for ongoing management. The feasibility and process of this transition varies between NHS regions and depends on local commissioning policies.
Key requirements for transitioning to NHS Shared Care typically include:
- A formal ADHD diagnosis from a suitably qualified specialist, whether NHS or private
- Evidence of an appropriate titration period with documented medication response
- A completed clinical assessment summary from the private prescriber
- A willing GP practice able to enter into a Shared Care Agreement
- Compatibility with local Integrated Care Board commissioning policies
- Suitable clinical criteria being met for the specific medication prescribed
Local policy variation: Whether a GP practice will accept a private ADHD diagnosis for NHS Shared Care purposes depends on local ICB policy, which varies across England, Wales, Scotland, and Northern Ireland. Patients should discuss this with both their private specialist and their GP before assuming that a private pathway will lead to NHS Shared Care support.
During any transition or prescribing responsibility change, Pharmazon HomeCare can provide continuity of medication supply, ensuring patients do not experience supply gaps that disrupt their ADHD treatment. Our team works with both the private specialist and the GP practice to coordinate prescriptions and maintain the prescribing record throughout the transition process.
Supporting patients through NHS and private ADHD transitions
Pharmazon HomeCare maintains medication continuity throughout Shared Care transitions and prescriber changes — speak to our team about how we can support your patients.
ADHD Prescription Handling: NHS and Private
NHS ADHD prescriptions are issued on FP10 forms (or electronically via EPS) and are subject to standard NHS prescription charges. Private ADHD prescriptions are issued on private prescription forms by authorised prescribers and carry the full cost of the medication. Both prescription types require identical controlled drug compliance from the dispensing pharmacy.
Whether a patient is managed through NHS or private channels, the pharmacy processes underpinning ADHD prescription fulfilment are governed by the same regulatory framework. ADHD medications as Schedule 2 controlled drugs require specific dispensing procedures, documentation, and supply chain compliance regardless of prescription type.
The key differences in prescription handling between NHS and private pathways relate to the prescription document used, the cost structure, and the dispensing channel:
NHS Prescriptions
- Issued on FP10 or via the Electronic Prescription Service (EPS)
- Standard NHS prescription charge or free for eligible patients
- Dispensed at NHS-contracted community pharmacy
- Prepayment Certificate available for patients on multiple medications
- Same controlled drug compliance requirements as private
Private Prescriptions
- Issued on private prescription form by authorised prescriber
- Full medication cost plus dispensing fee applies
- Can be dispensed at specialist pharmacy with home delivery
- Secure digital transfer to specialist pharmacy available
- Same controlled drug compliance requirements as NHS
How Pharmazon HomeCare Supports NHS & Private ADHD Patients
Pharmazon HomeCare is a GPhC-registered specialist pharmacy homecare provider supporting patients across both NHS and private ADHD treatment pathways. Our services are designed to address the specific requirements of ADHD prescription fulfilment, including controlled drug governance, repeat prescribing management, and direct-to-patient medication delivery, in a way that standard community pharmacy cannot replicate.
We work directly with specialist ADHD clinics, consultant psychiatrists, independent prescribers, NHS services, and GP practices operating under Shared Care Agreements to provide consistent, reliable, and clinically appropriate medication support.
Prescription Fulfilment
End-to-end processing of NHS and private ADHD prescriptions, including clinical validation, controlled drug dispensing, and full audit trail documentation.
Repeat Prescribing Management
Proactive monitoring of each patient's prescribing cycle with advance alerts to prescribers, preventing the supply gaps that disrupt ADHD treatment continuity.
Medication Home Delivery
Secure tracked delivery of ADHD medication directly to patients across the UK, meeting MHRA supply chain requirements for Schedule 2 controlled drugs.
Shared Care Coordination
Coordinating between specialist clinics and GP practices to maintain medication continuity through Shared Care transitions and ongoing prescribing arrangements.
Patient Communication
Direct patient support for prescription tracking, delivery status, and supply queries, reducing inbound administrative calls to clinic and GP practice teams.
Controlled Drug Governance
Complete controlled drug register management, regulatory compliance, and clinical governance reporting for both NHS and private prescribing partners.
Learn more about ADHD medication support
Whether you are a patient, clinician, GP practice, or ADHD service manager, Pharmazon HomeCare can provide specialist pharmacy support across NHS and private ADHD pathways. Speak to our clinical team today.
Frequently Asked Questions: NHS & Private ADHD Services
ADHD Pharmacy Services from Pharmazon HomeCare
Explore the full range of specialist ADHD pharmacy services supporting patients, clinicians, and clinics across NHS and private pathways.